In this article, Chief Commercial Officer Edward Hensley shares his perspective on digital transformation for the specialty pharmaceutical industry with Drug Channels, one of the industry’s leading publications offering expert insights on pharmaceutical economics and drug distribution systems.
Whether launching a new product, innovating at mid-lifecycle or facing loss of exclusivity (LOE), Hensley makes the case that technology-first solutions improve efficiencies for patients and HCPs, increasing the likelihood of adoption for both the product and the technology driving differentiated experiences.